Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Treatments: Lobeline; Nicotine

Criteria

Inclusion Criteria:

• No interest in stopping ST use within 90 days of study entry

• Daily use of ST in the 6 months prior to study entry

Exclusion Criteria:

• Current use of tobacco or nicotine products, other than ST

• Current unstable medical and mental health conditions

• Use of any medication that may affect tobacco use or be affected by a reduction in tobacco use

• Pregnant or breastfeeding